Skip to main content

Table 2 Brevican expression and the clinicopathological characteristics of 60 patients with malignant glioma.

From: The role of brevican in glioma: promoting tumor cell motility in vitro and in vivo

Cases Brevican expression Brevican expression P value
positive cases (%) negative cases (%)
Age
 ≤50 25 (78.1) 7 (21.9) 0.10
 >50 16 (57.1) 12 (42.9)  
Gender
 Male 22 (73.3) 8 (26.7) 0.58
 Female 19 (63.3) 11 (36.7)  
Histological grade
 I 6 (40.0) 9 (60.0) 0.01
 II 9 (60.0) 6 (40.0)  
 III 12 (80.0) 3 (20.0)  
 IV 14 (93.3) 1 (6.7)  
Degree of differentiation
 Well 15 (50.0) 15 (50.0) 0.005
 Poorly 26 (86.7) 4 (13.3)